ANDREW COX: Open Payments
NPI 1891084711 · BELHAVEN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 61 payments from 14 companies in 2025. Trend: 2023 $1,018 · 2024 $978 · 2025 $872
Food & beverage: $872
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 20 | $183 |
| Amgen Inc. | 13 | $135 |
| AstraZeneca Pharmaceuticals LP | 3 | $135 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $107 |
| PFIZER INC. | 5 | $81 |
| Novo Nordisk Inc | 4 | $59 |
| Corcept Therapeutics | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $28 |
| GlaxoSmithKline, LLC. | 1 | $22 |
Products named: FREESTYLE LIBRE 2, XIFAXAN, FARXIGA, OTEZLA, EVENITY, NURTEC ODT, Korlym, Wegovy.
Industry payments across NC — which companies pay providers there.
